Lenalidomide in Combination With Plerixafor in Patients With Previously Treated Chronic Lymphocytic Leukemia.
Phase of Trial: Phase I
Latest Information Update: 07 Feb 2018
At a glance
- Drugs Plerixafor (Primary) ; Lenalidomide; Rituximab
- Indications Chronic lymphocytic leukaemia
- Focus Adverse reactions
- 03 May 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 08 Feb 2015 Planned End Date changed from 1 Jun 2016 to 1 Mar 2015 as reported by ClinicalTrials.gov record.
- 13 Nov 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.